Literature DB >> 15136342

Infliximab-associated retrobulbar optic neuritis.

Luis J Mejico.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15136342     DOI： 10.1001/archopht.122.5.793

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  13 in total

Review 1.  Advances in the diagnosis and immunotherapy for ocular inflammatory disease.

Authors:  Steven Yeh; Lisa J Faia; Robert B Nussenblatt
Journal:  Semin Immunopathol       Date:  2008-03-05       Impact factor: 9.623

2.  Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease.

Authors:  Benjamin Alexandre; Yves Vandermeeren; Olivier Dewit; Tom Moreels; Nanne de Boer; Anjan Dhar; Chris Ziady; Ariella Bar-Gil Shitrit; Flavio Steinwurz; Njegica Jojic; Giuseppe Costantino; Benoit Bihin; Jean-François Rahier; Konstantinos H Katsanos
Journal:  J Crohns Colitis       Date:  2016-01-12       Impact factor: 9.071

Review 3.  Extraintestinal manifestations and complications in inflammatory bowel diseases.

Authors:  Katja S Rothfuss; Eduard F Stange; Klaus R Herrlinger
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 4.  Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.

Authors:  Ippazio Cosimo Antonazzo; Emanuel Raschi; Luca Vignatelli; Elisa Baldin; Trond Riise; Roberto D'Alessandro; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Drug Saf       Date:  2017-09       Impact factor: 5.606

5.  Optic neuritis after infliximab therapy.

Authors:  César Faillace; João Ricardo Maltez de Almeida; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2011-12-25       Impact factor: 2.631

Review 6.  Identifying and Treating Ocular Manifestations in Psoriasis.

Authors:  Mahsaw Motlagh; Christopher Fortenbach; Howard I Maibach; Bobeck S Modjtahedi
Journal:  Am J Clin Dermatol       Date:  2021-11-03       Impact factor: 7.403

Review 7.  Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.

Authors:  Ismail Simsek; Hakan Erdem; Salih Pay; Gungor Sobaci; Ayhan Dinc
Journal:  Ann Rheum Dis       Date:  2007-04-24       Impact factor: 19.103

Review 8.  Infliximab and anterior optic neuropathy: case report and review of the literature.

Authors:  Jane W Chan; Alberto Castellanos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-15       Impact factor: 3.117

9.  Central nervous system demyelination associated with etanercept in a 51 years old woman.

Authors:  Wanis H Ibrahim; Mohammed Hammoudah; Naveed Akhtar; Hassan Al-Hail; Dirk Deleu
Journal:  Libyan J Med       Date:  2007-06-01       Impact factor: 1.657

10.  Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.

Authors:  E Andreadou; E Kemanetzoglou; Ch Brokalaki; M E Evangelopoulos; C Kilidireas; A Rombos; E Stamboulis
Journal:  Case Rep Neurol Med       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.